NewAmsterdam Pharma Company NV Ordinary Shares
Price & Volume
Stats
See more52W Range | $21.02-$42.20 |
Market Cap | $2.6B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $7.1M |
Revenue Growth (YoY) | -80.7% |
Gross Profit (12 Mos) | $7.1M |
Diluted EPS | -$2.16 |
News
See moreYahoo Finance • 12 days ago
How Novartis' Double-Stacked Failures Reverberated Through Biopharma
Yahoo Finance • 12 days ago
Novartis Trial Failure Sparks Biopharma Options Frenzy
Yahoo Finance • 12 days ago
How Novartis And Ionis' High-Profile Failure Reverberated Through Biopharma
Yahoo Finance • 12 days ago
Novartis drops 13% on trial failure, dragging Dyne and Sarepta
About
CEO | Dr. Michael Harvey Davidson FACC, Facp., M.D. |
Address | Gooimeer 2-35, Naarden, Netherlands, 1411 DC |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |